Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Views on the nature of chronic fatigue syndrome: content analysis.

Hossenbaccus Z, White PD.

JRSM Short Rep. 2013 Jan;4(1):4. doi: 10.1258/shorts.2012.012051. Epub 2013 Jan 14.

2.

Chronic fatigue syndrome in the media: a content analysis of newspaper articles.

Knudsen AK, Omenås AN, Harvey SB, Løvvik CM, Lervik LV, Mykletun A.

JRSM Short Rep. 2011 May;2(5):42. doi: 10.1258/shorts.2011.011016. Epub 2011 May 25.

3.

Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.

O'Dowd H, Gladwell P, Rogers CA, Hollinghurst S, Gregory A.

Health Technol Assess. 2006 Oct;10(37):iii-iv, ix-x, 1-121.

4.

A UK based review of recommendations regarding the management of chronic fatigue syndrome.

Mallet M, King E, White PD.

J Psychosom Res. 2016 Sep;88:33-5. doi: 10.1016/j.jpsychores.2016.07.008. Epub 2016 Jul 17.

6.

Physical and functional impact of chronic fatigue syndrome/myalgic encephalomyelitis in childhood.

Kennedy G, Underwood C, Belch JJ.

Pediatrics. 2010 Jun;125(6):e1324-30. doi: 10.1542/peds.2009-2644. Epub 2010 May 17.

PMID:
20478937
7.
11.
12.

In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.

Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M.

J Affect Disord. 2013 Sep 5;150(2):223-30. doi: 10.1016/j.jad.2013.03.029. Epub 2013 May 10.

PMID:
23664637
13.

Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome.

Hoad A, Spickett G, Elliott J, Newton J.

QJM. 2008 Dec;101(12):961-5. doi: 10.1093/qjmed/hcn123. Epub 2008 Sep 19.

PMID:
18805903
14.

Risk factors for chronic fatigue syndrome/myalgic encephalomyelitis: a systematic scoping review of multiple predictor studies.

Hempel S, Chambers D, Bagnall AM, Forbes C.

Psychol Med. 2008 Jul;38(7):915-26. Epub 2007 Sep 25. Review.

PMID:
17892624
15.

Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.

Knight SJ, Scheinberg A, Harvey AR.

J Adolesc Health. 2013 Aug;53(2):154-65. doi: 10.1016/j.jadohealth.2013.03.009. Epub 2013 May 1. Review.

PMID:
23643337
16.

Could cadmium be responsible for some of the neurological signs and symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Pacini S, Fiore MG, Magherini S, Morucci G, Branca JJ, Gulisano M, Ruggiero M.

Med Hypotheses. 2012 Sep;79(3):403-7. doi: 10.1016/j.mehy.2012.06.007. Epub 2012 Jul 12.

PMID:
22795611
17.

Conceptual model for physical therapist management of chronic fatigue syndrome/myalgic encephalomyelitis.

Davenport TE, Stevens SR, VanNess MJ, Snell CR, Little T.

Phys Ther. 2010 Apr;90(4):602-14. doi: 10.2522/ptj.20090047. Epub 2010 Feb 25.

PMID:
20185614
18.
19.

Professional and popular views of chronic fatigue syndrome.

MacLean G, Wessely S.

BMJ. 1994 Mar 19;308(6931):776-7. Review.

20.

Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.

Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.

Neuro Endocrinol Lett. 2009;30(6):715-22.

PMID:
20035260

Supplemental Content

Support Center